Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Mrpl37 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of MRPL37 mRNA] | CTD | PMID:22206623 | Mrpl37 | Mouse | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MRPL37 mRNA | CTD | PMID:22206623 | Mrpl37 | Mouse | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of MRPL37 mRNA | CTD | PMID:17555576 | Mrpl37 | Mouse | 17beta-estradiol | multiple interactions | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MRPL37 mRNA | CTD | PMID:26496021 | Mrpl37 | Mouse | 17beta-estradiol | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of MRPL37 mRNA | CTD | PMID:32145629 | Mrpl37 | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:31826744 | Mrpl37 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPL37 mRNA | CTD | PMID:18343893 and PMID:21570461 | Mrpl37 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MRPL37 mRNA | CTD | PMID:20959002 more ... | Mrpl37 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MRPL37 mRNA | CTD | PMID:15328365 more ... | Mrpl37 | Mouse | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:18343893 | Mrpl37 | Mouse | 2,4,6-trinitrotoluene | affects expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Trinitrotoluene affects the expression of MRPL37 mRNA | CTD | PMID:21346803 | Mrpl37 | Mouse | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:20959002 | Mrpl37 | Mouse | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23994337 | Mrpl37 | Mouse | 3-chloropropane-1,2-diol | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of MRPL37 protein | CTD | PMID:34915118 | Mrpl37 | Mouse | 6-propyl-2-thiouracil | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of MRPL37 mRNA | CTD | PMID:30047161 | Mrpl37 | Mouse | aconitine | decreases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Aconitine results in decreased expression of MRPL37 protein | CTD | PMID:33236894 | Mrpl37 | Mouse | all-trans-retinoic acid | decreases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MRPL37 mRNA | CTD | PMID:33167477 | Mrpl37 | Mouse | amitrole | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of MRPL37 mRNA | CTD | PMID:30047161 | Mrpl37 | Mouse | aristolochic acid A | increases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of MRPL37 mRNA | CTD | PMID:33212167 | Mrpl37 | Mouse | arsenite(3-) | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to MRPL37 mRNA] | CTD | PMID:32406909 | Mrpl37 | Mouse | arsenous acid | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MRPL37 protein] | CTD | PMID:26598702 | Mrpl37 | Mouse | azoxystrobin | increases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | azoxystrobin results in increased expression of MRPL37 mRNA | CTD | PMID:33512557 | Mrpl37 | Mouse | beta-lapachone | increases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of MRPL37 mRNA | CTD | PMID:38218311 | Mrpl37 | Mouse | beta-naphthoflavone | increases expression | EXP | | 6480464 | beta-Naphthoflavone results in increased expression of MRPL37 mRNA | CTD | PMID:23994337 | Mrpl37 | Mouse | bisphenol A | multiple interactions | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MRPL37 mRNA | CTD | PMID:26496021 | Mrpl37 | Mouse | bisphenol A | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of MRPL37 mRNA | CTD | PMID:25181051 | Mrpl37 | Mouse | Bisphenol B | increases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of MRPL37 protein | CTD | PMID:34186270 | Mrpl37 | Mouse | bisphenol F | increases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of MRPL37 protein | CTD | PMID:34186270 | Mrpl37 | Mouse | cadmium dichloride | decreases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of MRPL37 mRNA | CTD | PMID:33453195 | Mrpl37 | Mouse | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon analog results in increased expression of MRPL37 mRNA | CTD | PMID:25554681 | Mrpl37 | Mouse | copper(II) sulfate | decreases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MRPL37 mRNA | CTD | PMID:19549813 | Mrpl37 | Mouse | corosolic acid | decreases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | corosolic acid results in decreased expression of MRPL37 mRNA | CTD | PMID:37939859 | Mrpl37 | Mouse | coumestrol | increases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of MRPL37 mRNA | CTD | PMID:19167446 | Mrpl37 | Mouse | coumestrol | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPL37 mRNA | CTD | PMID:19167446 | Mrpl37 | Mouse | diarsenic trioxide | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MRPL37 protein] | CTD | PMID:26598702 | Mrpl37 | Mouse | Dibutyl phosphate | affects expression | ISO | MRPL37 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of MRPL37 mRNA | CTD | PMID:37042841 | Mrpl37 | Mouse | dibutyl phthalate | decreases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of MRPL37 mRNA | CTD | PMID:21266533 | Mrpl37 | Mouse | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of MRPL37 mRNA | CTD | PMID:17361019 and PMID:21266533 | Mrpl37 | Mouse | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL37 mRNA | CTD | PMID:30529165 | Mrpl37 | Mouse | diuron | decreases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Diuron results in decreased expression of MRPL37 mRNA | CTD | PMID:35967413 | Mrpl37 | Mouse | Enterolactone | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPL37 mRNA | CTD | PMID:19167446 | Mrpl37 | Mouse | enzyme inhibitor | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MRPL37 protein | CTD | PMID:23301498 | Mrpl37 | Mouse | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of MRPL37 mRNA | CTD | PMID:35436446 | Mrpl37 | Mouse | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of MRPL37 mRNA | CTD | PMID:30319688 | Mrpl37 | Mouse | fenthion | increases expression | EXP | | 6480464 | Fenthion results in increased expression of MRPL37 mRNA | CTD | PMID:34813904 | Mrpl37 | Mouse | finasteride | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of MRPL37 mRNA | CTD | PMID:24136188 | Mrpl37 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of MRPL37 mRNA] | CTD | PMID:22206623 | Mrpl37 | Mouse | gentamycin | decreases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of MRPL37 mRNA | CTD | PMID:22061828 | Mrpl37 | Mouse | gentamycin | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of MRPL37 mRNA | CTD | PMID:33387578 | Mrpl37 | Mouse | ivermectin | decreases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MRPL37 protein | CTD | PMID:32959892 | Mrpl37 | Mouse | lipopolysaccharide | decreases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of MRPL37 mRNA | CTD | PMID:31059760 | Mrpl37 | Mouse | lipopolysaccharide | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL37 mRNA | CTD | PMID:31059760 | Mrpl37 | Mouse | methimazole | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of MRPL37 mRNA | CTD | PMID:30047161 | Mrpl37 | Mouse | paracetamol | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL37 mRNA | CTD | PMID:31059760 | Mrpl37 | Mouse | paracetamol | decreases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MRPL37 mRNA | CTD | PMID:31059760 | Mrpl37 | Mouse | rotenone | increases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Rotenone results in increased expression of MRPL37 mRNA | CTD | PMID:33512557 | Mrpl37 | Mouse | SB 431542 | multiple interactions | ISO | MRPL37 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MRPL37 protein | CTD | PMID:37664457 | Mrpl37 | Mouse | sulfadimethoxine | increases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of MRPL37 mRNA | CTD | PMID:30047161 | Mrpl37 | Mouse | sulindac | decreases expression | ISO | Mrpl37 (Rattus norvegicus) | 6480464 | Sulindac results in decreased expression of MRPL37 mRNA | CTD | PMID:24136188 | Mrpl37 | Mouse | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of MRPL37 mRNA | CTD | PMID:17555576 | Mrpl37 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of MRPL37 gene and titanium dioxide results in decreased methylation of MRPL37 promoter alternative form | CTD | PMID:35295148 | Mrpl37 | Mouse | valproic acid | increases expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MRPL37 mRNA | CTD | PMID:23179753 | Mrpl37 | Mouse | valproic acid | affects expression | ISO | MRPL37 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MRPL37 mRNA | CTD | PMID:25979313 | |